Literature DB >> 1581356

De novo methylation of transfected CAT gene plasmid constructs in F9 mouse embryonal carcinoma cells.

A Hasse1, W A Schulz, H Sies.   

Abstract

To study the formation of DNA methylation patterns, plasmids containing promoters of different strengths in front of the bacterial chloramphenicol acetyltransferase reporter gene were transfected into F9 mouse embryonal carcinoma cells. Methylation of the integrated plasmids as well as copy numbers and activities of the reporter gene were determined for individual cell clones. The methylation pattern of the integrated plasmids was found to be determined by properties of the DNA sequence itself. In contrast, the specific methylation patterns were invariant with respect to integration site, copy number and arrangement of the integrates; methylation did also not correlate with transcriptional activity of the different promoters. Certain promoter regions may therefore contain signals recognized by the de novo methylation activity in embryonal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581356     DOI: 10.1016/0167-4781(92)90092-e

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Recognition and suppression of transfected plasmids by protein ZNF511-PRAP1, a potential molecular barrier to transgene expression.

Authors:  Guo-Hua Qiu; Carol Ho-Wing Leung; Tong Yun; Xiaojin Xie; Mirtha Laban; Shing Chuan Hooi
Journal:  Mol Ther       Date:  2011-05-03       Impact factor: 11.454

2.  Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer.

Authors:  A N Magewu; P A Jones
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

3.  Demethylation of somatic and testis-specific histone H2A and H2B genes in F9 embryonal carcinoma cells.

Authors:  Y C Choi; C B Chae
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.